Mindfulness Therapy Significantly Improves Treatment-Resistant Depression: Study
The study found that remote mindfulness sessions improved depression symptoms, potentially offering new hope to hundreds of thousands of patients currently considered at the 'end of the road' for psychological treatment options.
Measurable Benefits Comparable to Medication
The
MBCT combines meditation and mindfulness practices, such as self-compassion, with CBT, which helps individuals change negative thought patterns.
The trial involved more than 200 patients across the UK who had already received talk therapy and anti-depressants but still struggled with depression.
Participants were divided into two groups. The intervention group received MBCT sessions in addition to standard treatment. These sessions focused on developing mindfulness skills and managing difficult emotions. The other group continued with their usual care, which included a combination of antidepressants and talk therapy.
Six months later, those who received MBCT showed greater improvements in their depression scores than those receiving standard care.
Related Stories
5/5/2025
11/28/2014
The group that received MBCT plus usual treatment had depression scores that were about 2.5 points lower on average on the Patient Health Questionnaire-9, a widely used screening tool for depression.
Remote delivery of MBCT can be 'really effective,' especially for people who might not be able to attend in-person sessions due to location, time, or mental health struggles, Dr. Sanam Hafeez, neuropsychologist and director of Comprehend the Mind in New York, who was not involved in the study, told The Epoch Times.
'Being able to join from home could actually help some people feel more comfortable opening up,' she said. If the sessions are structured well and the group is engaged, the impact could be just as strong.'
Why MBCT Works for Persistent Depression
MBCT is particularly helpful for people with recurrent or persistent depression, especially if they still have symptoms after standard treatment, Erik Larson, a board-certified psychiatric-mental health nurse practitioner, owner of Larson Mental Health, and not involved in the study, told The Epoch Times.
It was originally developed to prevent relapse in those with multiple episodes of depression, because it teaches people how to relate differently to negative thoughts and emotions instead of trying to get rid of them.
While MBCT works best for those who ruminate or feel overwhelmed by stress, experts caution it requires emotional stability and consistent practice, making it unsuitable for patients in acute crisis or with psychotic symptoms.
'[MBCT] helps people to recognize negative, self-critical thoughts as thoughts, rather than as facts and so helps to lessen their emotional impact,'
Hafeez said MBCT could be combined with other treatments.
'A lot of people already take medication, and this could give them extra support,' she said. 'It doesn't replace therapy like CBT but adds another layer. Some might even find it helps them rely less on medication over time.'
Treatment-resistant depression
Mary Ryan, a patient adviser and co-author who has worked with the research team from the start, emphasized in a
She said people have often been told that they've reached the 'end of the road' for psychological treatment, and there are no other options for them.
'The findings of this trial are hugely important because we're telling this group of people that they still matter—that there's something else we can try that may work for them,' she stated.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
a day ago
- Time Business News
Specialized Programs Available at Certain Inpatient Rehab Centers
Addiction recovery is a complex process, and for many individuals, it is further complicated by co-occurring mental health conditions. This combination, known as dual diagnosis, requires specialized treatment that addresses both addiction and mental health disorders simultaneously. Traditional rehab programs may not always provide the comprehensive care needed in these situations, which is why certain inpatient rehab centers offer specialized dual diagnosis programs. This article explores what dual diagnosis means, the challenges patients face, and how specialized inpatient programs are designed to improve recovery outcomes. True recovery requires more than determination; it needs access to professional guidance and structured routines. Specialized facilities provide medical care, therapy, and emotional support that help residents overcome addiction. The distraction-free environment allows for reflection and growth while fostering new habits that support long-term health. Group sessions and individual counseling encourage a deeper understanding of personal struggles. With continuous supervision, participants are guided toward balance and stability. Choosing inpatient rehab centers ensures individuals experience comprehensive healing, addressing every part of recovery so they can move forward with confidence and renewed strength. Dual diagnosis refers to the presence of both a substance use disorder and a mental health disorder in the same individual. Common examples include depression and alcohol addiction, anxiety and opioid misuse, or bipolar disorder combined with stimulant abuse. These conditions often influence each other, making recovery more complicated. For example, untreated depression can trigger substance use, while prolonged drug use can worsen underlying mental health issues. Standard addiction treatment programs may focus primarily on substance use without addressing mental health, which can leave major underlying issues unresolved. This increases the likelihood of relapse. Specialized dual diagnosis programs take a more holistic approach, ensuring that both conditions are diagnosed, managed, and treated together. This integrated care model creates better chances of long-term recovery. Inpatient rehab centers with dual diagnosis programs start with a thorough evaluation. Patients are assessed by a team of professionals, including psychiatrists, psychologists, and addiction specialists. This assessment identifies the mental health conditions present, the severity of substance use, and any medical complications. With this information, an individualized treatment plan is created to address all aspects of the patient's health. Specialized programs emphasize therapies that treat both addiction and mental health conditions. Therapists commonly use Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT). These methods address negative thought patterns, emotional regulation, and coping strategies. These therapies help patients manage mental health symptoms while building healthier habits that support sobriety. Some dual diagnosis patients require medications for mental health stabilization. In inpatient settings, these medications are carefully prescribed and monitored by medical professionals. The controlled environment of inpatient rehab ensures that medications are used properly, reducing the risk of misuse and providing stability during recovery. Patients with dual diagnosis often face higher risks during withdrawal or early recovery. Inpatient programs provide around-the-clock medical supervision to ensure safety and support. This supervision is especially critical for patients with severe psychiatric conditions, as their needs may fluctuate and require immediate medical attention. Group therapy sessions in dual diagnosis programs are designed for individuals who share similar challenges. These sessions allow patients to connect with peers who understand the struggle of managing both addiction and mental illness. This peer support fosters empathy, reduces stigma, and creates a community of encouragement. Families often struggle to understand the complexities of dual diagnosis. Specialized programs frequently include family therapy and education to help loved ones learn how to support recovery effectively. This involvement helps reduce enabling behaviors, improves communication, and builds a healthier home environment for when the patient transitions back. Dual diagnosis patients often face higher relapse risks, which is why specialized programs focus heavily on relapse prevention. Patients are taught practical coping strategies to handle both substance cravings and mental health triggers. By addressing both sides of the challenge, these programs reduce the likelihood of setbacks and strengthen long-term recovery. Recovery does not end when inpatient treatment is completed. Specialized programs provide aftercare plans that include outpatient therapy, medication management, and continued support for mental health. Ongoing care ensures that patients maintain stability as they reintegrate into daily life. Depression and alcohol addiction Anxiety disorders and benzodiazepine misuse Bipolar disorder and stimulant abuse PTSD and opioid addiction Schizophrenia with concurrent substance use By recognizing and treating these combinations, inpatient rehab centers provide a path to recovery that considers the full picture of a patient's health. Treating dual diagnosis can be complex. Some patients may resist medication, struggle with denial, or face severe psychiatric episodes. Specialized programs are equipped to manage these challenges with compassion and expertise. Having access to a multidisciplinary team makes it easier to adapt treatment plans as patient needs change. Comprehensive care for both addiction and mental health Reduced relapse risk Improved quality of life Stronger family support systems Better long-term outcomes These benefits highlight why specialized programs are often essential for individuals with dual diagnosis. Dual diagnosis requires a unique approach that standard rehab programs may not fully address. Inpatient rehab centers that offer specialized dual diagnosis programs provide integrated care, combining therapy, medication management, and continuous support. By treating both addiction and mental health conditions together, these programs create stronger foundations for recovery and equip patients with the tools needed for long-term success. For anyone struggling with both mental health challenges and addiction, specialized inpatient rehab programs represent one of the most effective paths toward healing and stability. TIME BUSINESS NEWS
Epoch Times
3 days ago
- Epoch Times
Why Eating Right Beats Eating Less, Says Weight-Loss Expert
Many people try dieting to lose weight, but ultimately fail to maintain results. Obesity specialist Cai Mingjie warned on The Epoch Times' 'Health 1+1' program that traditional dieting is often difficult to sustain, and most people regain weight within one or two years. He noted that the key to weight loss lies not in eating less but in eating the right way and in the right proportions. This approach not only helps you lose weight successfully but also prevents weight regain later. Why Is It So Easy to Regain Weight After Dieting? When people begin their weight loss journey, the first thing that comes to mind is 'eating less.' While this approach may show initial results, Cai said that the risk of regaining lost weight is extremely high. There are three primary reasons for this pattern: Decreased Basal Metabolic Rate When the body senses insufficient caloric intake, it activates a self-protective mechanism, lowering its basal metabolic rate to conserve energy. This metabolic slowdown reduces calorie burning, causing fatigue and lack of energy. This self-protection also increases cravings for high-calorie foods, making it easy to overeat and regain weight. Muscle Loss Dieting not only reduces fat but could also lead to a loss of muscle mass. Because it requires a fair amount of energy to maintain muscles, the body will try to reduce energy consumption by breaking down muscle tissue to make up for the caloric deficit. As muscle loss occurs, metabolism slows further, increasing the risk of weight regain. Psychological Factors
Medscape
3 days ago
- Medscape
Digital Therapeutic May Reduce Recurrent Suicide Attempts
TOPLINE: A smartphone-based digital therapeutic application designed to deliver suicide-focused cognitive-behavioral therapy (CBT) was associated with a sustained reduction in suicidal ideation through 24 weeks post-discharge and a 58% reduced rate of suicide attempts compared to a control application among adult inpatients with prior attempts, a new study showed. However, the study did not meet its primary endpoint of difference between treatments for 'time to first actual suicide attempt' in those with no prior attempts. METHODOLOGY: The multisite, double-blind, randomized clinical trial included more than 300 adults with an increased risk for suicide (mean age, 28 years; 66% women; 67% White) across six psychiatric inpatient units in the US from 2022 to 2024. Of these, 170 had prior suicide attempts. All participants were given treatment as usual during and after enrollment and were randomly assigned to also receive either 12 sessions of CBT educational modules via a smartphone application called OTX-202 (digital therapy group; n = 168) or common information and materials via a control smartphone application (control group; n = 171). The primary outcome was number of days from randomization until first actual suicide attempt. Secondary outcomes were score changes on the Scale for Suicide Ideation and clinician-rated clinical improvement at week 24. Follow-up data were available for 79% of participants, with assessments conducted via remote interview at weeks 4, 8, 12, 24, 52, 78, and 104. TAKEAWAY: Participants in the digital therapy group completed fewer mean number of sessions than those in the control group (4.4 vs 5.9; P = .02), and about 16% and 8% of the groups had at least one suicide attempt during the follow-up (P = .06), respectively. One death by suicide occurred during the study in the control group. Time to first actual suicide attempt and the adjusted rate of suicide attempts did not differ significantly between the treatment groups for those with no prior attempts. The cumulative probability of suicide attempt at 12 months was higher in the digital therapy group than in the control group (18% vs 9%). However, among patients with prior suicide attempts, those in the digital therapy group had a significant reduction in the rate of repeat suicide attempts during the follow-up compared with those in the control group (0.70 vs 1.68 attempts per person-year; adjusted rate ratio, 0.42; P = .04); each completed digital therapy module was associated with a 14% decrease in the suicide attempt rate; and their odds of clinical improvement were higher (odds ratio, 7.6; P = .04). The digital therapy group also showed a sustained reduction in suicidal ideation between weeks 12 and 24, whereas the control group showed an increased suicidal ideation during this period. The number, nature, and severity of adverse events did not differ significantly between the groups at 24 weeks. IN PRACTICE: 'Although suicide-specific therapy is highly effective for reducing suicidal thoughts and urges, finding therapists who know how to do this life-saving therapy after leaving the hospital can be challenging,' lead study investigator Craig J. Bryan, PsyD, the Ohio State University College of Medicine, Columbus, Ohio, said in a press release. Co-investigator Patricia Simon, PhD, Yale School of Medicine, New Haven, Connecticut, added, 'The weeks and months following a suicide crisis and discharge from a hospital are among the highest risk periods for suicide attempts and mortality, making it imperative to offer effective, suicide-specific interventions during this vulnerable window. OTX-202 addresses this critical need.' SOURCE: This study was published online on August 8 in JAMA Network Open. LIMITATIONS: This study was limited by a smaller sample size and baseline differences between treatment groups despite randomization. The results were not generalizable to patients not engaged in hospital settings. The requirement of smartphone ownership potentially excluded patients with low socioeconomic status. The trial also lacked sufficient power to detect differences in suicide deaths. DISCLOSURES: This study was funded by Oui Therapeutics Inc. and the National Institute of Mental Health. Several investigators, including Bryan and Simon, reported having financial and other ties with various sources and receiving funds from Oui Therapeutics Inc. Full details are provided in the original article. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
